Heart Disease Clinical Trials in Seattle

Showing 241-245 of 245 trials

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

NCT00385385

The objective of this study is to evaluate an antibiotic therapy called Rifalazil to determine its effect on hardening of the carotid arteries.

Coronary Artery DiseaseCerebrovascular DiseasePeripheral Vascular Disease

ActivBiotics72 participantsStarted Oct 2006

Lansing, Michigan, United States • Roslyn, New York, United States • Stony Brook, New York, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

NCT00048425

The purpose of this study is to evaluate the efficacy of a 24-hour infusion of levosimendan compared with placebo in the treatment of decompensated chronic heart failure.

Heart Failure, Congestive

Abbott600 participantsStarted Sep 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +163 more locations

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

Heart Disease Trials in Other Cities

ARISE - Aggressive Reduction of Inflammation Stops Events

Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass Procedures

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

Other Conditions in Seattle